Gene · 316
Papers2,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exosomes: Potential Next-Generation Nanocarriers for the Therapy of Inflammatory Diseases. | Pharmaceutics | 2023 | 37765245 | PubTator, text mining | PubMed |
Integrated Network Pharmacology, Molecular Docking, Molecular Simulation, and In Vitro Validation Revealed the Bioactive Components in Soy-Fermented Food Products and the Underlying Mechanistic Pathways in Lung Cancer. | Nutrients | 2023 | 37764733 | PubTator, text mining | PubMed |
| Challenges and Opportunities for In Vitro-In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation. | Drug Metab Dispos | 2023 | 37751998 | PubTator, text mining | PubMed |
| A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines. | J Biol Chem | 2023 | 37690691 | PubTator, text mining | PubMed |
| Reduction of Hydrogen Peroxide by Human Mitochondrial Amidoxime Reducing Component Enzymes. | Molecules | 2023 | 37687214 | PubTator, text mining | PubMed |
| Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. | J Med Chem | 2023 | 37669040 | PubTator, text mining | PubMed |
| Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016-2022). | Pharmaceuticals (Basel) | 2023 | 37631077 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality. | Life (Basel) | 2023 | 37629602 | PubTator, text mining | PubMed |
| Allopurinol and oxypurinol differ in their strength and mechanisms of inhibition of xanthine oxidoreductase. | J Biol Chem | 2023 | 37625592 | PubTator, text mining | PubMed |
| Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions: Research Methods and Applications. | Metabolites | 2023 | 37623842 | PubTator, text mining | PubMed |
| Sex- and APOE-specific genetic risk factors for late-onset Alzheimer's disease: Evidence from gene-gene interaction of longevity-related loci. | Aging Cell | 2023 | 37621137 | PubTator, text mining | PubMed |
| Knockout of Sema4D alleviates liver fibrosis by suppressing AOX1 expression. | Pharmacol Res | 2023 | 37591326 | PubTator, text mining | PubMed |
| Identification and validation of immune-related hub genes based on machine learning in prostate cancer and AOX1 is an oxidative stress-related biomarker. | Front Oncol | 2023 | 37583929 | PubTator, text mining | PubMed |
| Does the Micronutrient Molybdenum Have a Role in Gestational Complications and Placental Health? | Nutrients | 2023 | 37571285 | PubTator, text mining | PubMed |
| Bringing Nitric Oxide to the Molybdenum World-A Personal Perspective. | Molecules | 2023 | 37570788 | PubTator, text mining | PubMed |
| Nutritional Provision of Iron Complexes by the Major Allergen Alt a 1 to Human Immune Cells Decreases Its Presentation. | Int J Mol Sci | 2023 | 37569310 | PubTator, text mining | PubMed |
| Proteomic Analysis of Testicular Interstitial Fluid in Men with Azoospermia. | Eur Urol Open Sci | 2023 | 37545847 | PubTator, text mining | PubMed |
| Declaration: Novel SLC3A1 mutation in a cystinuria patient with xanthine stones: a case report. | BMC Urol | 2023 | 37525149 | PubTator, text mining | PubMed |
| The Absolute Bioavailability and Absorption, Metabolism, and Excretion of Ipatasertib, a Potent and Highly Selective Protein Kinase B (Akt) Inhibitor. | Drug Metab Dispos | 2023 | 37524543 | PubTator, text mining | PubMed |
| The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies. | Molecules | 2023 | 37513232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/316/papers?page=9